Dr. Patrick G. Ticman, MD

Dr. Ticman practices at Southwest Medical in Las Vegas, Nevada.

Dr. Ticman's NPI, 1306935473, was assigned on October 12, 2006. Dr. Ticman holds Nevada license 12055.

Dr. Ticman's primary practice is Southwest Medical, at 4475 S Eastern Ave, Las Vegas, NV 89119-7826. The practice phone is (702) 579-3253.

Dr. Ticman's primary practice is Southwest Medical in Las Vegas, Nevada. The medical group on file is Southwest Medical Associates. Dmand AI also links Dr. Ticman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ticman practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ticman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ticman is licensed in Nevada.

CMS data shows 144 Medicare services from Dr. Ticman across 1 procedure code in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $7,835 for them. Every service was in an office.

CMS counts 72 Medicare patients who saw Dr. Ticman in 2024. The largest group is 65 to 74, with 33 patients. 69% of them have high blood pressure, and 67% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ticman's median patient age at 71, with 51% women.

In 2024, Dr. Ticman wrote 9,149 Medicare Part D claims for 878 patients. 86% of them were for generic drugs. CMS names the drug for 8,561 of them, across 112 drugs with 11 or more claims each, at $834,347 in total drug cost. In 2023, CMS named 10,182 claims across 127 drugs.

Dr. Ticman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 118 general payments to Dr. Ticman from 21 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $383.